Dr. Arifur Rahman, MBBS, FCPS, FUICC
Clinical Oncologist & Cancer Research Pioneer
My journey into oncology began during my medical school years when I witnessed the profound impact that compassionate, evidence-based care could have on patients facing their greatest challenge. What started as a calling to help others became a lifelong commitment to advancing cancer treatment through both clinical excellence and groundbreaking research.
For over 15 years, I have dedicated my career to not just treating cancer, but to understanding it at its most fundamental level. My approach combines cutting-edge medical science with the deeply human understanding that behind every diagnosis is a person, a family, and a story that deserves our utmost care and attention.
My Philosophy of Care
Every patient deserves personalized treatment that addresses not just their cancer, but their unique circumstances, concerns, and goals.
Precision Over Generalization
I believe that every tumor is unique, and so is every patient. That is why I focus on precision oncology—using advanced genetic insights, molecular profiling, and biomarkers to design treatment strategies tailored specifically to each individual. By moving beyond “one-size-fits-all” approaches, I aim to provide therapies that are more effective, targeted, and personalized.
Innovation with Affordability
Cutting-edge cancer care should never be out of reach. While I embrace the latest advances in targeted treatments and precision medicine, I remain equally committed to making these options accessible. By carefully balancing innovation with cost considerations, I ensure my patients receive the best available therapies without unnecessary financial strain.
Holistic Responsibility in Cancer Care
Cancer treatment is not just about fighting a disease—it is about caring for a person. My philosophy integrates scientific precision with compassion, addressing not only the clinical outcomes but also the emotional and economic well-being of each patient. I see it as my responsibility to deliver care that is advanced, affordable, and deeply human.
Educational Background & Career Milestones
A comprehensive journey through medical education, specialized training, and professional achievements in oncology.
Bangladesh Specialized Hospital PLC
Consultant
Oncology & Radiotherapy, Organization: Bangladesh Specialized Hospital PLC
Labaid Cancer Hospital And Super Specialty Center
Practicing Consultant
Practicing Consultant, Oncology & Radiotherapy, Since January 2022 Organization: Labaid Cancer Hospital And Super Specialty Center
Delta Medical College and Hospitals
Practicing Consultant
Practicing Consultant, Oncology & Radiotherapy, Since April 2020 Organization: Delta Medical College and Hospitals
Bangladesh College of Physicians and Surgeons (BCPS)
FCPS
FCPS, Radiotherapy under BCPS (Bangladesh College of Physicians and Surgeons)
National Institute of Cancer Research & Hospital
MD, Radiation Oncology, Part-1
MD, Part-1, Radiation Oncology at National Institute of Cancer Research & Hospital, Mohakhali for the July 2011 session under university of BSMMU.
Rangpur Medical College & Hospital
MBBS
Obtained MBBS degree from Rangpur Medical College under Rajshahi University
Notre Dame College, Dhaka
Higher Secondary Certificate (HSC)
Passed from Notre Dame College, Dhaka, under Dhaka Board in 1st Division in the year of 1999.
Seroil Govt School, Rajshahi
Secondary School Certificate (SSC)
Passed from Seroil Govt School, Rajshahi, under Rajshahi Board in 1st Division
Medicine Club, Rangpur Medical College Unit
Life Member, MC RpMC Unit
Working with a Student Organization named Medicine Club, presently as Central Advisor & Life Member of RpMC unit
Bangladesh Soceity For Breast Cancer Study
Organisin Secretary, BSBCS
Bangladesh Society for Breast Cancer Study (BSBCS) is a Government registered non-profit organization and its motto is to enhance the level of evidence based practice of breast cancer treatment in Bangladesh.
Hospital Affiliations
Privileged to practice at world-renowned medical institutions committed to excellence in cancer care.
Amrita Institute of Medical Science (AIMS), Kochi, India
High Precision Radiotherapy Treatment at Radiation Oncology Department under Dr. Debnarayan Dutta, MD, HOD- Radiation Oncology Dept, Amrita Institute of Medical Science (AIMS), Kochi, India (4 weeks, from 15 April 2019 to 10 May 2019)
Harvard Medical School
HMX Pro Immunology- Immuno-oncology Harvard Medical School (Online Learning External Education)
Square Hospitals Ltd
Position: Clinical Staff (CS) Worked as RMO & Clinical Staff (CS) in the dept. of Square Oncology & Radiotherapy Center at Square Hospitals Ltd from January 2010 to April 2016.
Showing 1 to 3 of 5 hospital affiliations
Professional Memberships
Active participation in leading medical societies and professional organizations.
MBBS
Member of Bangladesh Medical & Dental Association (BMDC), Registration No- A 43908.
FCPS
Fellow of Bangladesh College of Physicians and Surgeons (BCPS) - ID- 5878
FUICC
Association of Union for International Cancer Control (UICC) Fellows and participated in a Virtual Fellowship with an expert from Amsterdam UMC - Vrije Universiteit Amsterdam, Netherlands in 2021 entitled “Stereotaxy in Oligo-metastatic Disease”
Showing 1 to 3 of 9 professional memberships
Awards & Recognition
Honored to receive recognition from peers and institutions for contributions to cancer care and research.
Wiley Reviewer Certificate
This certificate is awarded to for serving as a reviewer for reviewing 1 manuscript in 2024
2024
BMJ Case Reports Reviewer Certificate
Open as a webpage BMJ Case Reports Dear Md., I wanted to thank you for your time and dedication in reviewing manuscripts for BMJ Case Reports. As a result of your contribution, we are able to continue publishing the best papers that advance science and support healthcare professionals and researchers around the world. In recognition of your contribution, your name has been added to the annual list of reviewers* on the journal website. You can also find other reviewer benefits that BMJ offers on the author hub. Thank you once again, and I hope that you will continue to support the journal in 2023 and beyond. Best wishes, Seema Biswas Editor-in-Chief BMJ Case Reports
2023
BICC 2025
Honered to had Speaking engagement at BICC 2025 at Satellite Symposium by AstraZeneca (MGH) for "Role of Osimertinib in combination with Chemotherapy for EGFR positive Metastatic NSCLC- FLAURA 2 Study with RW Patient"
31 Oct 2025
Speaking Engagements
Sharing knowledge and insights at leading medical conferences worldwide.
Bangladesh International Cancer Congress 2023 (BICC'23) on 14 September 2023.
Impact of Fractionated Stereotactic Radiotherapy (FSRT) in case of Oligo brain metastasis in a single centre experience. Oral Abstract Presented in Bangladesh International Cancer Congress 2023 (BICC'23) on 14 September 2023.
Bangladesh International Cancer Congress 2024 (BICC'24) on 14 December 2024
Survival Analysis of CNS patients in Bangladesh – focusing the multidisciplinary approaches among 149 patients in a single centre retrospective analysis from 2018- 2023. Oral Abstract Presented in Bangladesh International Cancer Congress 2024 (BICC'24) on 14 December 2024
18th Annual Meeting of the Korean Society of Medical Oncology & 2025 International Conference (KSMO 2025)
Survival Analysis of CNS patients in Bangladesh – focusing the multidisciplinary approaches among 149 patients in a single centre retrospective analysis from 2018- 2023. Poster Presentation at KSMO 2025
Showing 4 to 6 of 7 speaking engagements
Continuing Medical Education
Committed to lifelong learning and staying at the forefront of medical advances.
ESTRO Meet ASIA 2024
August 2024Malaysia
APCCC 2024
April 2024Advanced Prostate Cancer Consensus Conference (APCCC) held from the 25th to the 27th of April 2024, Lugano, Switzerland.
FARO 2024
May 2024Free Breathing VMTA vs DIBH 3DCRT Breast Carcinoma
Showing 7 to 9 of 36 continuing education items
Ready to Begin Your Journey to Recovery?
I'm here to provide the compassionate, expert care you deserve. Let's work together to develop a personalized treatment plan that gives you the best possible outcome. Key Treatment Areas Breast Cancer Lung Cancer Ovarian & Gynecologic Cancer Gastrointestinal Cancer Genitourinary (Prostate, Bladder, Kidney) Neuro-oncology “Learn how we tailor treatment using biomarkers, targeted agents, and immunotherapy.”